![]() |
|
|
Vol. 60, Issue 3, 421-426, September 2001
Department of Pharmacy, Center of Drug Research, University of
Munich, Munich, Germany
Background: The inducible nitric-oxide synthase (iNOS)
synthesizes NO from L-arginine. Availability of
L-arginine is maintained by a lipopolysaccharide
(LPS)-induced induction of the CAT-2B amino acids transporter.
Recently, we could show that the cardiovascular hormone atrial
natriuretic peptide (ANP) inhibits the induction of iNOS in
LPS-stimulated macrophages via its guanylate cyclase-coupled
A-receptor. Purpose: To investigate whether ANP exerts an
effect on LPS-induced L-arginine uptake.
Methods: Murine bone marrow derived macrophages were
activated with LPS (1 µg/ml, 20 h) in the presence or absence of
ANP or C-type natriuretic peptide (CNP). L-Arginine
transport was determined by measuring the uptake of
L-[3H]arginine.
L-[3H]Arginine influx was also
determined in LPS-activated cells in the presence of
NG-monomethyl-L-arginine
(L-NMMA), competitor amino acids, or ANP. Nitrite
accumulation was determined in supernatants of LPS-activated cells
cultured in the presence or absence of
L-ornithine. Results: ANP dose
dependently (10
8-10
6M)
inhibited LPS-induced
L-[3H]arginine uptake
when added simultaneously with LPS, whereas it showed no effect when
added simultaneously with
L-[3H]arginine. The
effect was abrogated by the A-receptor antagonist HS-142-1 (10 µg/ml). CNP (10
6 M) did not influence
L-arginine transport. Competitor amino acids (10
2 M) inhibited
L-[3H]arginine uptake. An
excess of unlabeled L-arginine
(10
2 M) as well as its analog
L-NMMA (10
3 M) also
reduced L-[3H]arginine
influx. L-Arginine uptake was critical for
production of NO because L-ornithine
significantly decreased LPS-induced nitrite accumulation.
Conclusion: This work demonstrates that ANP inhibits
LPS-induced L-arginine uptake via its guanylate cyclase-coupled A-receptor. Besides its influence on the induction of
iNOS, this effect may represent an important and unique mechanism by
which ANP regulates NO production in macrophages.
This article has been cited by other articles:
![]() |
A. Y. Chong, A. D. Blann, J. Patel, B. Freestone, E. Hughes, and G. Y.H. Lip Endothelial Dysfunction and Damage in Congestive Heart Failure: Relation of Flow-Mediated Dilation to Circulating Endothelial Cells, Plasma Indexes of Endothelial Damage, and Brain Natriuretic Peptide Circulation, September 28, 2004; 110(13): 1794 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Weber, S. B. Blumenthal, T. Hartung, A. M. Vollmar, and A. K. Kiemer ANP inhibits TNF-{alpha}-induced endothelial MCP-1 expression--involvement of p38 MAPK and MKP-1 J. Leukoc. Biol., November 1, 2003; 74(5): 932 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Kiemer, N. Bildner, N. C. Weber, and A. M. Vollmar Characterization of Heme Oxygenase 1 (Heat Shock Protein 32) Induction by Atrial Natriuretic Peptide in Human Endothelial Cells Endocrinology, March 1, 2003; 144(3): 802 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Kiemer, N. C. Weber, R. Furst, N. Bildner, S. Kulhanek-Heinze, and A. M. Vollmar Inhibition of p38 MAPK Activation via Induction of MKP-1: Atrial Natriuretic Peptide Reduces TNF-{alpha}-Induced Actin Polymerization and Endothelial Permeability Circ. Res., May 3, 2002; 90(8): 874 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Kiemer, N. C. Weber, R. Furst, N. Bildner, S. Kulhanek-Heinze, and A. M. Vollmar Inhibition of p38 MAPK Activation via Induction of MKP-1: Atrial Natriuretic Peptide Reduces TNF-{alpha}-Induced Actin Polymerization and Endothelial Permeability Circ. Res., May 3, 2002; 90(8): 874 - 881. [Abstract] [Full Text] [PDF] |
||||